Hormone Therapy

Top Story

Fat mass reduced, quality of life unchanged with testosterone therapy following cancer

Fat mass reduced, quality of life unchanged with testosterone therapy following cancer
November 12, 2019
FDA News

FDA issues complete response letter for new oral testosterone formulation

November 11, 2019
The FDA has issued a complete response letter regarding a new drug application for an oral formulation of testosterone undecanoate, according to a press release from…

Court case highlights misconceptions surrounding pediatric transgender care

October 29, 2019
A Texas court case involving a custody dispute over a young child who may identify as transgender has ignited a national debate about the appropriate course of pediatric…
FDA News

FDA approves Liletta to prevent pregnancy for up to 6 years

October 28, 2019
The FDA approved a supplemental new drug application for the hormone-releasing intrauterine device Liletta 52 mg that extends the device’s duration for pregnancy…
More Headlines »
CME ABIM MOC

Ace the Case: Patient With a 20-Year History of Type 2 Diabetes Mellitus and Concern Regarding the Risk of Coronary Heart Disease

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the management of risk in a 72-year-old man with T2DM.
More »
Video
Meeting News

VIDEO: AACE wants clinical endocrinologists to ‘get inspired’

April 25, 2019
More »
CME ABIM MOC

Best of Obesity Forum® 2018

This activity is supported by an educational grant from Novo Nordisk, Inc.

The incidence of obesity has increased dramatically over the past 20 years and is considered to be an epidemic in the…
More »